Kit for aided-diagnosis and prognostic evaluation on glioblastoma based on gene CLCF1 and use method thereof
A glioblastoma, auxiliary diagnosis technology, applied in the field of prognostic evaluation kit, glioblastoma auxiliary diagnosis, can solve the problem of few clinical significance research, achieve the effect of objective evaluation and reduced survival time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment
[0034] The experimental methods in the following examples are conventional methods unless otherwise specified, and the involved experimental reagents and materials are conventional biochemical reagents and materials unless otherwise specified.
[0035] 1. TCGA database comparison of CLCF1 differential expression in LGG and GBM
[0036] The Cancer Genome Atlas (TCGA) project team was originally composed of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), and developed into A very large data research platform. Low-grade glioma (LGG) and glioblastoma (GBM), as one of the earliest tumors studied, have a large number of comprehensive data results. The LGG and GBM data in TCGA come from (https: / / genome-cancer.ucsc.edu), in which LGG included 530 tumor samples, and GBM included 167 samples. The results of CLCF1 gene transcription level are from the RNA-seq results of the Illumina HiSeq sequencing platform. figure 1 It is the expression ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com